Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Genes Section Short Communication TRIP11 (thyroid hormone receptor interactor 11) Jean-Loup Huret Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France Published in Atlas Database: February 1998 Online version is available at: http://AtlasGeneticsOncology.org/Genes/CEV14.html DOI: 10.4267/2042/32096 This work is licensed under a Creative Commons Attribution-Non commercial-No Derivative Works 2.0 France Licence. © 1998 Atlas of Genetics and Cytogenetics in Oncology and Haematology Identity Implicated in Location: 14q32 t(5;14)(q33;q32)/ANLL → CEV14/PDGFRb DNA/RNA Disease Transcription Poorly known: 1 case of ANLL. Major transcripts: 7, 9 and 10.5 kb; coding sequence: 2.2 kb. Cytogenetics Protein Hybrid/Mutated Gene Description Abnormal Protein Found as an additional anomaly. 5' CEV14 - 3' PDGFRb. 729 amino acids; contains a N-term leucine zipper and a C-term putative thyroid hormone receptor interacting domain. Leucine zipper from CEV14 fused to the transmembrane domain and the Tyr kinase domain of PDGFRb. Expression References Is wide; high expression in heart, muscle, pancreas; found expressed in hematopoietic cell lines. Abe A, Emi N, Tanimoto M, Terasaki H, Marunouchi T, Saito H. Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. Blood 1997 Dec 1;90(11):4271-7. Function May be a transcriptional factor. This article should be referenced as such: Huret JL. TRIP11 (thyroid hormone receptor interactor 11). Atlas Genet Cytogenet Oncol Haematol.1998;2(1):9. Atlas Genet Cytogenet Oncol Haematol. 1998; 2(1) 9